Tirzepatide vs Semaglutide | GLP-1 Comparison Guide

Two of the most popular GLP-1 medications today are semaglutide (sold as Ozempic and Wegovy) and tirzepatide (sold as Mounjaro and Zepbound). While both help with weight loss and blood sugar management, they have meaningful differences in how they work, how effective they are, and what you might expect in terms of side effects.

How They Work: Single vs Dual Action

The most fundamental difference is in their mechanism of action:

Semaglutide is a GLP-1 receptor agonist. It mimics one hormone—GLP-1—which helps regulate blood sugar and appetite.

Tirzepatide is a dual GIP/GLP-1 receptor agonist. It mimics both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), two hormones that work together to regulate metabolism.

Think of it this way: semaglutide hits one target, while tirzepatide hits two. This dual action is one reason tirzepatide has shown higher average weight loss percentages in clinical trials.

Effectiveness for Weight Loss

Both medications produce significant weight loss, but tirzepatide has demonstrated greater average weight loss in head-to-head studies.

Semaglutide (Wegovy) Clinical Data

In the STEP trials, people taking semaglutide 2.4 mg lost approximately 15-17% of their body weight over 68 weeks on average.

Tirzepatide (Zepbound) Clinical Data

In the SURMOUNT trials, people taking tirzepatide 15 mg lost approximately 20-22% of their body weight over 72 weeks on average.

That difference—roughly 5-7 percentage points—can be significant for someone with a large amount of weight to lose. However, individual results vary widely based on diet, exercise, starting weight, and other factors.

Effectiveness for Blood Sugar Control

Both medications are FDA-approved for type 2 diabetes and effectively lower HbA1c.

Semaglutide can reduce HbA1c by approximately 1.5-2.0% at higher doses.

Tirzepatide has shown HbA1c reductions of approximately 2.0-2.5% at higher doses.

Again, tirzepatide shows slightly higher average efficacy, but both are highly effective for blood sugar control.

Side Effects: How Do They Compare?

Both medications share a similar side effect profile since they work on the same GLP-1 pathway. The most common side effects for both are:

Nausea

Vomiting

Diarrhea

Constipation

Injection site reactions

Tirzepatide may cause slightly higher rates of nausea and vomiting in some people due to its dual action, though this varies individually. Starting with a low dose and gradually titrating up (as prescribed) helps minimize these effects for both medications.

Dosing and Administration

Semaglutide

Taken as a once-weekly subcutaneous injection. Doses start low and are gradually increased every 4 weeks up to a maintenance dose (typically 2.4 mg for weight loss).

Tirzepatide

Also taken as a once-weekly subcutaneous injection. Doses start low and are gradually increased every 4 weeks up to a maximum of 15 mg.

Both come in pre-filled pens, making injection relatively simple. Neither requires refrigeration after initial use (though some formulations have specific storage requirements—always check the label).

Cost and Availability

Both medications can be expensive without insurance coverage. Prices vary by pharmacy and location. Both are currently available, though tirzepatide may have more variable supply due to higher demand.

Check with your insurance provider about coverage. Some plans cover one but not the other, or have different copays depending on whether the medication is prescribed for diabetes or weight loss.

Which Should You Choose?

There's no universal answer—it depends on your individual health profile, goals, and how you respond to each medication. Here are some general considerations:

Choose semaglutide if you want a well-established medication with extensive long-term data, or if you've had good results with GLP-1 therapy previously.

Choose tirzepatide if you're looking for potentially greater weight loss results and your healthcare provider believes you're a good candidate for the dual-action approach.

The most important step is working with a healthcare provider who can assess your specific situation and recommend the best option for you. Track your symptoms and progress using PeptPro to share detailed data with your provider at each visit.

Frequently Asked Questions

Is tirzepatide more effective than semaglutide?

Clinical trials suggest tirzepatide produces higher average weight loss percentages than semaglutide—approximately 20-22% vs 15-17% of body weight. However, individual results vary, and both are effective medications.

Can I switch from semaglutide to tirzepatide?

Yes, under medical supervision. Some people switch if they're not achieving desired results with semaglutide. Your healthcare provider will guide you on how to transition safely, typically starting at a low dose of tirzepatide.

Do both medications need to be refrigerated?

Unopened pens should be refrigerated. Once in use, most formulations can be stored at room temperature for a limited period. Always follow the specific storage instructions that come with your medication.

Which medication has fewer side effects?

Both medications have similar side effect profiles, primarily gastrointestinal. Some people tolerate one better than the other. Starting with low doses and titrating gradually helps minimize side effects for both.

Does insurance cover tirzepatide vs semaglutide?

Coverage varies by insurance plan. Some plans cover both, some cover only one, and some may require prior authorization. Check with your insurance provider to understand your specific coverage and any step therapy requirements.

Tirzepatide vs Semaglutide: Which GLP-1 Medication Is Right for You?

How They Work: Single vs Dual Action